Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitors

John L. Musachio, Jinsoo Hong, Masanori Ichise, Nicholas Seneca, Amira K. Brown, Jeih San Liow, Christer Halldin, Robert B. Innis, Victor W. Pike, Rong He, Jia Zhou, Alan P. Kozikowski

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

11C-labeled (+)-trans-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsu lfanyl]ethanol ([11C]5) and (+)-trans-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsu lfanyl]-1-(piperidin-1-yl)ethanone ([11C]6) were synthesized and evaluated as new imaging agents for the norepinephrine transporter (NET). [11C]5 and [11C]6 display high affinity for the NET in vitro (Ki = 0.94 and 0.68 nM, respectively) and significant selectivity over the dopamine (DAT) and serotonin transporters (SERT). Because of their high affinity and favorable transporter selectivities we speculated that these ligands might serve as useful PET agents for imaging NET in vivo. Contrary to our expectations, both of these ligands provided brain images that were more typical of those shown by agents binding to the DAT.

Original languageEnglish (US)
Pages (from-to)3101-3104
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume16
Issue number12
DOIs
StatePublished - Jun 15 2006
Externally publishedYes

Fingerprint

Norepinephrine Plasma Membrane Transport Proteins
Neuroimaging
Brain
Imaging techniques
Ligands
Serotonin Plasma Membrane Transport Proteins
Dopamine Plasma Membrane Transport Proteins
Dopamine
Ethanol
methyl 4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylate
modafinil

Keywords

  • Antidepression
  • Brain imaging agents
  • DAT radioligands
  • Monoamine transporter inhibitors
  • NET radioligands
  • PET imaging

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Musachio, J. L., Hong, J., Ichise, M., Seneca, N., Brown, A. K., Liow, J. S., ... Kozikowski, A. P. (2006). Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitors. Bioorganic and Medicinal Chemistry Letters, 16(12), 3101-3104. https://doi.org/10.1016/j.bmcl.2006.03.066

Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitors. / Musachio, John L.; Hong, Jinsoo; Ichise, Masanori; Seneca, Nicholas; Brown, Amira K.; Liow, Jeih San; Halldin, Christer; Innis, Robert B.; Pike, Victor W.; He, Rong; Zhou, Jia; Kozikowski, Alan P.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 16, No. 12, 15.06.2006, p. 3101-3104.

Research output: Contribution to journalArticle

Musachio, JL, Hong, J, Ichise, M, Seneca, N, Brown, AK, Liow, JS, Halldin, C, Innis, RB, Pike, VW, He, R, Zhou, J & Kozikowski, AP 2006, 'Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitors', Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 12, pp. 3101-3104. https://doi.org/10.1016/j.bmcl.2006.03.066
Musachio, John L. ; Hong, Jinsoo ; Ichise, Masanori ; Seneca, Nicholas ; Brown, Amira K. ; Liow, Jeih San ; Halldin, Christer ; Innis, Robert B. ; Pike, Victor W. ; He, Rong ; Zhou, Jia ; Kozikowski, Alan P. / Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitors. In: Bioorganic and Medicinal Chemistry Letters. 2006 ; Vol. 16, No. 12. pp. 3101-3104.
@article{6603e228b8794bb7a030c23eef6e3a01,
title = "Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitors",
abstract = "11C-labeled (+)-trans-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsu lfanyl]ethanol ([11C]5) and (+)-trans-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsu lfanyl]-1-(piperidin-1-yl)ethanone ([11C]6) were synthesized and evaluated as new imaging agents for the norepinephrine transporter (NET). [11C]5 and [11C]6 display high affinity for the NET in vitro (Ki = 0.94 and 0.68 nM, respectively) and significant selectivity over the dopamine (DAT) and serotonin transporters (SERT). Because of their high affinity and favorable transporter selectivities we speculated that these ligands might serve as useful PET agents for imaging NET in vivo. Contrary to our expectations, both of these ligands provided brain images that were more typical of those shown by agents binding to the DAT.",
keywords = "Antidepression, Brain imaging agents, DAT radioligands, Monoamine transporter inhibitors, NET radioligands, PET imaging",
author = "Musachio, {John L.} and Jinsoo Hong and Masanori Ichise and Nicholas Seneca and Brown, {Amira K.} and Liow, {Jeih San} and Christer Halldin and Innis, {Robert B.} and Pike, {Victor W.} and Rong He and Jia Zhou and Kozikowski, {Alan P.}",
year = "2006",
month = "6",
day = "15",
doi = "10.1016/j.bmcl.2006.03.066",
language = "English (US)",
volume = "16",
pages = "3101--3104",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitors

AU - Musachio, John L.

AU - Hong, Jinsoo

AU - Ichise, Masanori

AU - Seneca, Nicholas

AU - Brown, Amira K.

AU - Liow, Jeih San

AU - Halldin, Christer

AU - Innis, Robert B.

AU - Pike, Victor W.

AU - He, Rong

AU - Zhou, Jia

AU - Kozikowski, Alan P.

PY - 2006/6/15

Y1 - 2006/6/15

N2 - 11C-labeled (+)-trans-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsu lfanyl]ethanol ([11C]5) and (+)-trans-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsu lfanyl]-1-(piperidin-1-yl)ethanone ([11C]6) were synthesized and evaluated as new imaging agents for the norepinephrine transporter (NET). [11C]5 and [11C]6 display high affinity for the NET in vitro (Ki = 0.94 and 0.68 nM, respectively) and significant selectivity over the dopamine (DAT) and serotonin transporters (SERT). Because of their high affinity and favorable transporter selectivities we speculated that these ligands might serve as useful PET agents for imaging NET in vivo. Contrary to our expectations, both of these ligands provided brain images that were more typical of those shown by agents binding to the DAT.

AB - 11C-labeled (+)-trans-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsu lfanyl]ethanol ([11C]5) and (+)-trans-2-[[(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidin-3-yl]methylsu lfanyl]-1-(piperidin-1-yl)ethanone ([11C]6) were synthesized and evaluated as new imaging agents for the norepinephrine transporter (NET). [11C]5 and [11C]6 display high affinity for the NET in vitro (Ki = 0.94 and 0.68 nM, respectively) and significant selectivity over the dopamine (DAT) and serotonin transporters (SERT). Because of their high affinity and favorable transporter selectivities we speculated that these ligands might serve as useful PET agents for imaging NET in vivo. Contrary to our expectations, both of these ligands provided brain images that were more typical of those shown by agents binding to the DAT.

KW - Antidepression

KW - Brain imaging agents

KW - DAT radioligands

KW - Monoamine transporter inhibitors

KW - NET radioligands

KW - PET imaging

UR - http://www.scopus.com/inward/record.url?scp=33747103205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747103205&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2006.03.066

DO - 10.1016/j.bmcl.2006.03.066

M3 - Article

VL - 16

SP - 3101

EP - 3104

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 12

ER -